Progression-free but no overall survival benefit for adult patients with bevacizumab therapy for the treatment of newly diagnosed glioblastoma: A systematic review and meta-analysis.

Category Systematic review
JournalCancers
Year 2019
This article has no abstract
Epistemonikos ID: 8fb4c359452a63436bd6f7bb1c323b7b7441d4f2
First added on: Nov 29, 2019